Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors

The Journal of Clinical Investigation
J A GonzaloJ C Gutierrez-Ramos

Abstract

Eosinophil accumulation is a distinctive feature of lung allergic inflammation. Here, we have used a mouse model of OVA (ovalbumin)-induced pulmonary eosinophilia to study the cellular and molecular mechanisms for this selective recruitment of eosinophils to the airways. In this model there was an early accumulation of infiltrating monocytes/macrophages in the lung during the OVA treatment, whereas the increase in infiltrating T-lymphocytes paralleled the accumulation of eosinophils. The kinetics of accumulation of these three leukocyte subtypes correlated with the levels of mRNA expression of the chemokines monocyte chemotactic peptide-1/JE, eotaxin, and RANTES (regulated upon activation in normal T cells expressed and secreted), suggesting their involvement in the recruitment of these leukocytes. Furthermore, blockade of eotaxin with specific antibodies in vivo reduced the accumulation of eosinophils in the lung in response to OVA by half. Mature CD4+ T-lymphocytes were absolutely required for OVA-induced eosinophil accumulation since lung eosinophilia was prevented in CD4+-deficient mice. However, these cells were neither the main producers of the major eosinophilic chemokines eotaxin, RANTES, or MIP-1alpha, nor did they reg...Continue Reading

References

Aug 1, 1992·The American Review of Respiratory Disease·H NakajimaS Yoshida
Oct 1, 1992·Current Opinion in Cell Biology·T Schweighoffer, S Shaw
Jan 30, 1992·The New England Journal of Medicine·D S RobinsonA B Kay
Apr 1, 1992·The Journal of Allergy and Clinical Immunology·A M BentleyA B Kay
Mar 6, 1992·Cell·P MombaertsV E Papaioannou
Aug 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·P F WellerR R Lobb
Oct 11, 1990·The New England Journal of Medicine·J BousquetP Godard
Feb 1, 1990·The Journal of Allergy and Clinical Immunology·G J Gleich
Nov 13, 1989·Journal of Immunological Methods·N Van Rooijen
Jun 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·B J RollinsC D Stiles
Jun 1, 1970·The Journal of Experimental Medicine·A Basten, P B Beeson
Dec 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·A O FelsW A Scott
Jun 1, 1984·European Journal of Immunology·E Van VlietW Van Ewijk
Feb 1, 1994·The Journal of Experimental Medicine·C A DahindenM Baggiolini
Oct 1, 1995·The Journal of Experimental Medicine·P D CollinsT J Williams
Sep 12, 1995·Proceedings of the National Academy of Sciences of the United States of America·M E RothenbergP Leder
Mar 1, 1995·The Journal of Experimental Medicine·M E RothenbergP Leder
Jul 1, 1994·The Journal of Experimental Medicine·H XuJ C Gutierrez-Ramos
Sep 27, 1994·Proceedings of the National Academy of Sciences of the United States of America·B WangC Terhorst
Jun 1, 1994·American Journal of Respiratory Cell and Molecular Biology·S H GavettM Wills-Karp
Jan 1, 1993·The Journal of Experimental Medicine·S K BeggI Bertoncello
Apr 1, 1993·American Journal of Respiratory Cell and Molecular Biology·M B Resnick, P F Weller
Jan 1, 1996·The Journal of Experimental Medicine·J M DrazenK F Austen

❮ Previous
Next ❯

Citations

Nov 10, 1998·European Journal of Immunology·A BraunH Renz
Mar 10, 2001·Biochemical and Biophysical Research Communications·T SaekiK Noguchi
Feb 10, 2000·Springer Seminars in Immunopathology·U SyrbeA Hamann
Mar 17, 2007·Cellular and Molecular Life Sciences : CMLS·S G Trivedi, C M Lloyd
Dec 4, 2004·Cell and Tissue Research·Ugur Gonlugur, Tanseli Efeoglu
Jan 25, 2003·Current Allergy and Asthma Reports·Heidi Isenberg-FeigAndrea Keane-Myers
Jan 25, 2003·Current Allergy and Asthma Reports·Mi-Na Kweon, Hiroshi Kiyono
Mar 31, 2010·Clinical Reviews in Allergy & Immunology·Juan Raymundo Velazquez, Luis Manuel Teran
Dec 23, 2008·Archives of Pharmacal Research·Ok-Kyoung KwonHyeong-Kyu Lee
Oct 24, 2002·European Journal of Pharmacology·Judith ScheerensGert Folkerts
Nov 27, 2002·European Journal of Pharmacology·Yuntao WanShelby P Umland
May 7, 1998·European Journal of Pharmacology·P A Henricks, F P Nijkamp
Jan 5, 2002·Atherosclerosis·William S ShinStanley G Rockson
Jan 22, 2003·Journal of Immunological Methods·Daniele D'AmbrosioFrancesco Sinigaglia
Sep 19, 2003·The Journal of Allergy and Clinical Immunology·Susumu IsogaiJames G Martin
Dec 6, 1997·The Journal of Allergy and Clinical Immunology·B S Bochner
Jul 13, 2002·Pharmacology & Therapeutics·Y Riffo-Vasquez, D Spina
Feb 12, 1998·Trends in Pharmacological Sciences·C G PerssonF Sundler
Oct 26, 1999·Immunology Today·J C Gutierrez-RamosJ A Gonzalo
Jun 24, 1998·International Journal of Immunopharmacology·A D KraneveldF P Nijkamp
Mar 14, 1998·Research in Immunology·N Wagner
Aug 28, 1998·Research in Immunology·V P KurupP S Murali
May 30, 2001·Bioorganic & Medicinal Chemistry Letters·D DhanakJ R White
Jun 6, 2003·Bioorganic & Medicinal Chemistry·Wieslaw KazmierskiTerry Kenakin
Feb 13, 2003·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Olivier RaiskyMarlene L Rose
Aug 31, 2001·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·K P Leong, D P Huston
Jan 19, 2000·Molecular Medicine Today·S M RankinT J Williams
Oct 18, 2003·Cytokine & Growth Factor Reviews·Peter J Barnes
Jul 27, 1999·Current Opinion in Chemical Biology·M K Schwarz, T N Wells
Aug 7, 2003·Current Opinion in Pharmacology·Clare M Lloyd, Sara M Rankin
Oct 2, 2004·Nature Reviews. Drug Discovery·Peter J Barnes
Mar 6, 2002·British Journal of Pharmacology·André KleinMauro M Teixeira
Oct 30, 1999·Clinical and Experimental Immunology·K SakaiK Hiwada
Mar 2, 2002·Immunology·Clare Lloyd
Feb 12, 1998·The New England Journal of Medicine·A D Luster

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.